Shorter dual antiplatelet therapy after drug-coated balloon for coronary disease
Part of Heart & circulation clinical trials.
This study tests whether a shorter period of dual blood-thinning therapy (two medicines) is as safe and effective as the standard longer period after a drug-coated balloon procedure for blocked heart arteries. You may join if you've already had the procedure and have been stable for a month.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with chronic heart artery disease (also called chronic coronary syndrome).
- You had a drug-coated balloon procedure to open a blocked artery, and in the month after, you did not have a heart attack, stroke, or major bleeding.
- You are currently taking a combination of two blood-thinning medicines (aspirin plus a P2Y12 inhibitor like clopidogrel or ticagrelor).
- You are willing to take part in the study and follow its requirements.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a drug-coated balloon (medicated balloon) to a drug-eluting stent (medicated mesh tube) for treating new blockages in heart arteries. It is designed for patients with a high risk of bleeding who have completed a short course of anti-clotting medication and have been event-free for at least one year.
This trial compares taking a single blood thinner (aspirin) for 1 month versus 6 months after a special balloon treatment (called a drug-coated balloon, or DCB) to open a blocked heart artery. The goal is to see if the shorter course is just as safe and effective, meaning some people might avoid the risks of longer blood-thinner use.
This study compares whether patients who receive a special drug-coated balloon to open a blocked heart artery (without a stent) need to take one or two blood-thinning medications afterward. The goal is to find the safest and most effective approach for preventing future blockages.
This trial tests whether taking just one blood thinner (clopidogrel) is as safe and effective as taking two (clopidogrel plus aspirin) for older adults or people at high bleeding risk who have had a drug-coated balloon procedure to open blocked heart arteries.
This study compares taking blood-thinning medicine for 1 month versus 6 months after a balloon angioplasty to open a small heart artery. The goal is to find out which duration is safer and more effective for preventing future heart problems.
This study tests a shorter, gentler blood thinner plan after getting a heart stent. It is designed for people who have had a heart attack or unstable angina and who are at higher risk of bleeding, to help prevent future heart problems with less bleeding risk.
Hear when a new Chronic Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.